Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of Mirvaso (CD07805/47) in facial erythema of rosacea
NCT01789775Phase 3Completed
- Sponsor
- Galderma
- Start
- Dec 2012
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of brimonidine transdermal lotion in rosacea, sponsored by Galderma. Started Dec 2012; status: completed.
02
Drugs
brimonidine transdermal lotion
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT01789775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01789775.